Cargando…

The agents of non-A, non-B viral hepatitis

Recent studies have provided physicochemical and electron microscopic evidence for the existence of two distinct agents of posttransfusion non-A, non-B (NANB) hepatitis. One of these agents is chloroform-resistant and is not associated with the formation of unique ultrastructural structures in infec...

Descripción completa

Detalles Bibliográficos
Autor principal: Bradley, Daniel W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 1985
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119509/
https://www.ncbi.nlm.nih.gov/pubmed/3923011
http://dx.doi.org/10.1016/0166-0934(85)90047-3
_version_ 1783514780528541696
author Bradley, Daniel W.
author_facet Bradley, Daniel W.
author_sort Bradley, Daniel W.
collection PubMed
description Recent studies have provided physicochemical and electron microscopic evidence for the existence of two distinct agents of posttransfusion non-A, non-B (NANB) hepatitis. One of these agents is chloroform-resistant and is not associated with the formation of unique ultrastructural structures in infected liver. The other agent is CHCl(3)-sensitive, induces the formation of characteristic hepatocyte cytoplasmic tubules, and interferes with concurrent HAV or HBV infection in experimentally inoculated chimpanzees. The tubule-forming agent (TFA) has also been shown to pass through an 80 nm capillary pore membrane filter, suggesting that it is a small enveloped (or lipid-containing) virus. The TFA can also be recovered from low titer (⩽ 10(5) infectious doses/ml) chronic-phase chimpanzee plasma by use of a multi-step purification procedure that assumes the agent is a small enveloped RNA virus with an approximate buoyant density of 1.24 g/cm(3) and a sedimentation coefficient of 200–280 S. The apparent lack of nucleic acid homology between the NANB-TFA and HBV further suggests that the NANB-TFA is either Togavirus-like or belongs to another or as yet undefined class of RNA or DNA virus.
format Online
Article
Text
id pubmed-7119509
institution National Center for Biotechnology Information
language English
publishDate 1985
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71195092020-04-08 The agents of non-A, non-B viral hepatitis Bradley, Daniel W. J Virol Methods Article Recent studies have provided physicochemical and electron microscopic evidence for the existence of two distinct agents of posttransfusion non-A, non-B (NANB) hepatitis. One of these agents is chloroform-resistant and is not associated with the formation of unique ultrastructural structures in infected liver. The other agent is CHCl(3)-sensitive, induces the formation of characteristic hepatocyte cytoplasmic tubules, and interferes with concurrent HAV or HBV infection in experimentally inoculated chimpanzees. The tubule-forming agent (TFA) has also been shown to pass through an 80 nm capillary pore membrane filter, suggesting that it is a small enveloped (or lipid-containing) virus. The TFA can also be recovered from low titer (⩽ 10(5) infectious doses/ml) chronic-phase chimpanzee plasma by use of a multi-step purification procedure that assumes the agent is a small enveloped RNA virus with an approximate buoyant density of 1.24 g/cm(3) and a sedimentation coefficient of 200–280 S. The apparent lack of nucleic acid homology between the NANB-TFA and HBV further suggests that the NANB-TFA is either Togavirus-like or belongs to another or as yet undefined class of RNA or DNA virus. Published by Elsevier B.V. 1985-04 2002-11-12 /pmc/articles/PMC7119509/ /pubmed/3923011 http://dx.doi.org/10.1016/0166-0934(85)90047-3 Text en Copyright © 1985 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Bradley, Daniel W.
The agents of non-A, non-B viral hepatitis
title The agents of non-A, non-B viral hepatitis
title_full The agents of non-A, non-B viral hepatitis
title_fullStr The agents of non-A, non-B viral hepatitis
title_full_unstemmed The agents of non-A, non-B viral hepatitis
title_short The agents of non-A, non-B viral hepatitis
title_sort agents of non-a, non-b viral hepatitis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119509/
https://www.ncbi.nlm.nih.gov/pubmed/3923011
http://dx.doi.org/10.1016/0166-0934(85)90047-3
work_keys_str_mv AT bradleydanielw theagentsofnonanonbviralhepatitis
AT bradleydanielw agentsofnonanonbviralhepatitis